Stock BIOVICA INTERNATIONAL AB
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Biovica International AB Nasdaq Stockholm

Equities

End-of-day quote Nasdaq Stockholm
Other stock markets
- SEK - Intraday chart for Biovica International AB
30/05 Biovica International AB Announces Divitum® Tka Results to Be Presented At Asco the Cancer Conference CI
13/04 Certain B Shares of Biovica International AB are subject to a Lock-Up Agreement Ending on 13-APR-2024. CI

Chart calendar Biovica International AB

ece5dc427ef.qrHspj4m9gOksg1U4vlK5MuaypC-33jO_Mh7POAUFeA._sm_33pXsTL-9UUls7UtirKo8sOJsRmUn_EXX697eI7u9tT-aBG5VpP7TA~7e7cfd417271a7f3d6ff2f1f73793025

Upcoming events on Biovica International AB

18/06/2024 Q4 2024 Earnings Release Pre-market
28/08/2024 Q1 2025 Earnings Release (Projected)
13/12/2024 Q2 2025 Earnings Release (Projected)
13/03/2025 Q3 2025 Earnings Release (Projected)
18/06/2025 Q4 2025 Earnings Release (Projected)

Past events on Biovica International AB

02/06/2024 07:30 pm American Society of Clinical Oncology Meeting
14/03/2024 07:30 pm Q3 2024 Earnings Call
14/03/2024 12:30 pm Q3 2024 Earnings Release
06/12/2023 07:30 pm Carlsquare Investor Day
05/12/2023 San Antonio Breast Cancer Symposium
28/11/2023 07:30 pm Q2 2024 Earnings Call
28/11/2023 12:30 pm Q2 2024 Earnings Release
23/11/2023 06:30 pm Extraordinary Shareholders Meeting
06/09/2023 06:30 pm Q1 2024 Earnings Call
06/09/2023 11:30 am Q1 2024 Earnings Release
05/09/2023 01:30 pm Annual General Meeting
21/06/2023 06:30 pm Q4 2023 Earnings Call
21/06/2023 Q4 2023 Earnings Release Pre-market
17/05/2023 04:30 pm Extraordinary Shareholders Meeting
17/03/2023 07:30 pm Q3 2023 Earnings Call
16/03/2023 12:50 pm Q3 2023 Earnings Release
15/12/2022 Interim 2023 Earnings Release Pre-market
09/12/2022 04:30 am San Antonio Breast Cancer Symposium - Poster P5-02-27
24/11/2022 Redeye Life Science Day
23/11/2022 10:30 am Investor Meeting

Annual results

Fiscal PeriodApril 2019 2020 2021 2022 2023 2024
Net sales
Million SEK		Released
Forecast
Spread 		3,01
3,10
-3.06%		1,67
3,00
-44.3%		2,08
3,00
-30.77%		2,05
1,00
104.5%		3,38
5,00
-32.34%
10,0

EBITDA
Million SEK		Released
Forecast
Spread 		-18,7
-16,0
-16.86%		-25,6
-32,2
20.23%		-34,0
-34,0
-0.11%		-53,7
-48,0
-11.8%		-102
-86,5
-18.15%
-106

EBIT
Million SEK		Released
Forecast
Spread 		-21,7
-20,0
-8.59%		-29,8
-38,0
21.54%		-40,2
-40,0
-0.45%		-60,1
-55,0
-9.27%		-110
-95,0
-16.21%
-116

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		-21,5
-19,0
-13.28%		-30,3
-37,7
19.74%		-39,4
-40,0
1.53%		-60,0
-45,5
-31.78%		-111
-95,0
-16.51%
-113

Net income
Million SEK		Released
Forecast
Spread 		-21,6
-19,0
-13.45%		-30,3
-28,4
-6.75%		-39,5
-40,0
1.3%		-60,0
-37,1
-61.68%		-110
-94,8
-16.59%
-115

EPS
SEK		Released
Forecast
Spread 		-1,23
-1,10
-11.82%		-1,29
-1,60
19.38%		-1,39
-1,42
2.11%		-2,11
-1,48
-42.59%		-3,18
-2,31
-37.95%
-7,42

Announcement Date14/06/1905/06/2017/06/2116/06/2221/06/23-

Quarterly results

Fiscal PeriodApril 2022 Q3 2022 Q4 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales
Million SEK		Released
Forecast
Spread


1,08








0,59
2,00
-70.65%		1,75
2,00
-12.3%		2,56
4,00
-35.93%		1,08
9,00
-88.06%
5,00













EBITDA
Million SEK		Released
Forecast
Spread 		-12,9
-11,1
-15.73%		-17,3





-27,2
-20,0
-36.2%		-35,2
-23,0
-53.27%		-29,8
-28,0
-6.58%		-22,9
-26,0
11.84%		-25,5
-27,0
5.44%
-27,7


-17,0


-17,0


-17,0


-13,0

EBIT
Million SEK		Released
Forecast
Spread 		-14,4
-11,1
-29.44%		-19,1





-29,3
-22,0
-33.08%		-37,2
-25,0
-49.13%		-32,2
-30,0
-7.31%		-25,3
-29,0
12.7%		-27,8
-28,5
2.29%
-30,4


-19,0


-19,0


-19,0


-16,0

Earnings before Tax (EBT)
Million SEK		Released
Forecast
Spread 		-14,3
-11,3
-27.31%		-19,1
-14,3
-33.58%


-29,2
-22,0
-32.64%		-37,2
-23,0
-61.75%		-31,9
-25,0
-27.78%		-23,8
-32,0
25.71%		-27,6
-35,0
21.19%
-34,3


-18,6


-18,5


-18,9


-14,9

Net income
Million SEK		Released
Forecast
Spread 		-14,3
-11,3
-27.34%		-19,1
-14,3
-33.46%		-23,3


-28,5
-22,0
-29.72%		-37,7
-22,9
-64.29%		-32,3
-24,8
-30.04%		-25,7
-31,7
18.86%		-27,3
-35,1
22.12%
-34,3


-18,6


-18,5


-18,9


-14,9

EPS
SEK		Released
Forecast
Spread 		-0,50
-0,31
-60.13%		-0,67
-0,40
-69.17%		-0,81


-0,64
-0,60
-6.67%		-0,81
-0,45
-79.66%		-0,70
-0,30
-133.33%		-0,56
-0,30
-86.67%		-0,44
-0,58
24.63%
-0,40


-0,22


-0,20


-0,19


-0,15

Announcement Date15/03/2216/06/2215/12/2216/03/2321/06/2306/09/2328/11/2314/03/24-----

Upcoming sector events for Biovica International AB

30/07/2024 VERACYTE, INC.: Q2 2024 Earnings Release (Projected)
30/07/2024 EXACT SCIENCES CORPORATION: Q2 2024 Earnings Release (Projected)
31/07/2024 ADAPTIVE BIOTECHNOLOGIES CORPORATION: Q2 2024 Earnings Release (Projected)
01/08/2024 CAREDX, INC: Q2 2024 Earnings Release (Projected)
01/08/2024 IOVANCE BIOTHERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected)
01/08/2024 GUARDANT HEALTH, INC.: Q2 2024 Earnings Release (Projected)
06/08/2024 MARAVAI LIFESCIENCES HOLDINGS, INC.: Q2 2024 Earnings Release (Projected)
14/08/2024 SEEGENE, INC.: Q2 2024 Earnings Release (Projected)
29/08/2024 BGI GENOMICS CO., LTD.: Q2 2024 Earnings Release (Projected)
28/10/2024 BGI GENOMICS CO., LTD.: Q3 2024 Earnings Release (Projected)
More events

Past sector events for Biovica International AB

10/05/2024 SEEGENE, INC.: Q1 2024 Earnings Release
10/05/2024 01:35 am GUARDANT HEALTH, INC.: Q1 2024 Earnings Release
10/05/2024 01:31 am IOVANCE BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release
09/05/2024 01:35 am MARAVAI LIFESCIENCES HOLDINGS, INC.: Q1 2024 Earnings Release
09/05/2024 01:35 am EXACT SCIENCES CORPORATION: Q1 2024 Earnings Release
08/05/2024 01:35 am VERACYTE, INC.: Q1 2024 Earnings Release
27/04/2024 BGI GENOMICS CO., LTD.: Q1 2024 Earnings Release
13/04/2024 BGI GENOMICS CO., LTD.: Q4 2023 Earnings Release
29/02/2024 02:35 am CAREDX, INC: Q4 2023 Earnings Release
29/02/2024 02:31 am IOVANCE BIOTHERAPEUTICS, INC.: Q4 2023 Earnings Release
  1. Stock Market
  2. Equities
  3. BIOVIC B Stock
  4. Stock
  5. Calendar Biovica International AB